The current valuation score of Immunic Inc is 9.19, ranking 49 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.01, which is -70.66% below the recent high of -0.30 and -1598.06% above the recent low of -17.22.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.